CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,707 | $587.54 | $1.6M | 329,144 |
| 2026-10-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,241 | $588.47 | $730K | 327,903 |
| 2026-10-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,280 | $589.64 | $755K | 326,623 |
| 2026-10-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −680 | $590.57 | $402K | 325,943 |
| 2026-10-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −694 | $591.60 | $411K | 325,249 |
| 2026-10-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −806 | $592.92 | $478K | 324,443 |
| 2026-10-26 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 157,410 | ||
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $577.68 | $116K | 333,743 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −700 | $578.80 | $405K | 333,043 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,038 | $579.74 | $602K | 332,005 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,017 | $580.78 | $591K | 330,988 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,650 | $581.82 | $960K | 329,338 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,732 | $582.78 | $1.0M | 327,606 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −427 | $583.83 | $249K | 327,179 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −676 | $584.77 | $395K | 326,503 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −778 | $585.99 | $456K | 325,725 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −542 | $586.93 | $318K | 325,183 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −740 | $588.00 | $435K | 324,443 |
| 2026-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 166,910 |
Page 12 of 64 · 1,267 trades